News Massive Bio Has Onboarded Over 100,000 Cancer Patients To Find Their Clinical Trial

Tomorrow’s Myelofibrosis Treatment Today

Access innovative myelofibrosis treatments with free clinical trial matching. Take the first step today!

Start Your Journey

Compliant with

    Find Your Treatment Now

    A Patient Advocate will reach out to you soon.

    Personal data is fully confidential and 100% secure

    You can receive a guidebook with information about myelofibrosis by filling out the form.

      Find Your Treatment Now

      A Patient Advocate will reach out to you soon.

      Personal data is fully confidential and 100% secure

      You can receive a guidebook with information about myelofibrosis by filling out the form.

      Understanding Your Options for Treating Myelofibrosis

      Are you a patient diagnosed with Myelofibrosis (MF) who is seeking innovative treatment options? Massive Bio can help you to access the latest therapies with free clinical trial matching.

      In order to be considered a suitable candidate for this innovative therapy, it is imperative that you meet the prescribed criteria as outlined below:

      • You have been diagnosed with Myelofibrosis (PMF, PPV-MF or PER-MF)
      • Patient has a TSS score of >/=12 OR 2 S/S with score >/= 3 OR Patient has splenomegaly
      • Patient has been on Ruxolitinib (Jakafi) for 6 months

      i. No change in the clinic

      ii. Suboptimal Response (but residual symptoms) OR Anemia Response

      iii. Progressive Disease (Splenomegaly) OR Unacceptable Cytopenias (intolerance to treatment)

      • For Sub-optimal response see below:
        Moderate response: Complete response in anemia with progression in splenomegaly or partial response in anemia without progression in splenomegaly or any response in splenomegaly without progression in anemia and constitutional symptoms.
      • Minor response: Any leukocyte- or platelet-based response without progression in anemia, splenomegaly, or constitutional symptoms.

      If you meet the eligibility criteria for this innovative myelofibrosis treatment, you can take the first step by filling out our medical record collection form.
      Massive Bio’s advanced Artificial Intelligence system will match and suggest a range of potential treatments for your unique medical situation.
      Our Patient Advocates will evaluate your submission and reach out to you promptly to discuss your eligibility for our myelofibrosis clinical trial.

      We prioritize the privacy and security of your information, so you can feel confident in using our service to find the best treatment options for you.

      Our service is completely free and can help connect you with promising new treatments that match your specific needs and eligibility criteria.

      This can save you time and effort in searching for clinical trials on your own.

      Myelofibrosis, a chronic myeloproliferative disease, can manifest as primary myelofibrosis, post-PV myelofibrosis, or post-ET myelofibrosis. Treatment options may include clinical trials for new therapies.


      What Are Clinical Trials? 
      A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments.That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.

      Why Massive Bio?
      Our AI matching tool makes cancer treatment simple.

      We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.

      Access the free matching tool

      How Massive Bio Helps Patients With Myelofibrosis

      Massive Bio specializes in finding clinical trials of new treatments for MF and related conditions. If you’ve been diagnosed with MF or any other myeloproliferative neoplasm, we’re here to help. That’s true even if you require advanced myelofibrosis treatment or advanced blood cancer treatment for any other type of myeloproliferative disorder. If your MF has progressed, let us help you find the best treatment options. Using our artificial intelligence-based platform, we can match you to clinical trials of advanced myelofibrosis treatment options today. If you aren’t sure if you have MF or a related condition, that’s okay. Additional testing can help determine your exact diagnosis.


      Hear from our Co founder & CEO

      Selin Kurnaz on how she struggled to find the right treatment for her uncle and started Massive Bio to help others.

      There is a major gap between what pharmaceutical companies are working on right now vs. what cancer patients are getting. Massive Bio is revolutionizing this process.
      Selin Kurnaz, Co-Founder, CEO
      People's stories
      Star Star Star Star Star

      “The patient advocate was knowledgable to understand my rare myelofibrosis case. The nurses were friendly and supported us through clinical trial enrollment process in a couple weeks. I am glad to see of your post on the social media groups.“

      Jess Hayle
      Myelofibrosis Patient
      Google Reviews

      Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.

      Mylan Tran
      Cancer Patient Caregiver
      Star Star Star Star Star

      I reached out to Massive Bio after learning of a recent breast cancer diagnosis of a family member. From free expert clinical trial matching to patient advocate support, Massive Bio was able to provide me with the necessary resources and knowledge to provide my family member the support they needed during their cancer journey.

      Josh K
      Cancer Patient
      Star Star Star Star Star

      I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.

      Jack Kulver
      Myelofibrosis Patient
      Star Star Star Star Star

      We reached out to Massive Bio for a second opinion regarding my Mothers breast cancer diagnosis. Massive Bio provided us with alternative treatment options which were clinically proven to be more effective and with less side effects than the standard level of care our oncologist suggested. Their team was quick to respond, extremely knowledgeable, answered all of our questions. They continue to follow her case, gladly reviewing any new scans and results. We are so grateful for the time and effort they continue to put into her case. Thank you Massive Bio for giving us hope again!

      Samantha Kingsbery
      Team Member
      Star Star Star Star Star

      Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.

      Samantha Swift
      Team Member
      Star Star Star Star Star
      You are in good hands

      Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.

      Call +1 844 627 7246
      Cancer Clinical Trials Patients Cancer Clinical Trials Patients

      What is a Myelofibrosis clinical trial?

      Clinical trials test the latest scientific advancements in Myelofibrosis treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Myelofibrosis patients might gain access to promising drugs and innovative treatments long before they're made available to the public.

      Cancer Ribbon
      Dr. Arturo explains:
      What Are Clinical Trials?

      Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new treatments. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important treatment option for many cancer patients.


      We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.